Jilin Deshang Pharmaceutical

Jilin Deshang Pharmaceutical is a national high-tech pharmaceutical enterprise in China that integrates drug research and development, production, and sales. Founded in 2012, the company operates a modern manufacturing base in the Huinan Economic Development Zone of Tonghua City, Jilin Province, featuring GMP-compliant production lines for both traditional Chinese patent medicines and chemical drugs. Its commercial product portfolio spans multiple therapeutic areas, including gastroenterology, hepatology, urology, endocrinology, and orthopedics. Key products include Yidanshu Granules for pancreatic and gallbladder conditions, and Yinchen Tuihuang Capsules for hepatitis. Jilin Deshang Pharmaceutical operates two wholly-owned subsidiaries: Jilin Detai Pharmaceutical and Beijing Mega Pharmaceutical Science and Technology, the latter of which serves as its dedicated R&D center.